share_log

Raymond James Initiates Coverage On Fulgent Genetics With Outperform Rating, Announces Price Target of $45

Raymond James Initiates Coverage On Fulgent Genetics With Outperform Rating, Announces Price Target of $45

雷蒙德·詹姆斯以优于大盘的评级启动对富金特遗传的报道,宣布目标价为45美元
Benzinga Real-time News ·  2022/11/18 07:31

Raymond James analyst Andrew Cooper initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $45.

Raymond James分析师安德鲁·库珀对Fulgent Genetics(纳斯达克:FLGT)发起报道,评级优于大盘,并宣布目标价为45美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发